The gut-brain axis in long COVID
Keywords:
SARS-CoV-2, Long COVID, Post-acute sequelae, Gut-brain axisAbstract
Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a complex multisystem disorder characterized by persistent neurological, gastrointestinal, and psychological symptoms. Emerging evidence suggests that dysfunction of the gut-brain axis plays an important role in the development and persistence of Long COVID manifestations. SARS-CoV-2 infection may cause long-term alterations in gut microbiota composition, resulting in dysbiosis, impaired intestinal barrier integrity, and chronic immune activation. Reduced abundance of beneficial microorganisms and decreased production of microbial metabolites, particularly short-chain fatty acids, may disrupt intestinal homeostasis and neuroimmune communication. Increased intestinal permeability and inflammatory signaling can contribute to systemic inflammation, vagus nerve dysfunction, and neuroinflammatory processes associated with cognitive impairment, fatigue, mood disturbances, and gastrointestinal symptoms. Therapeutic strategies targeting the gut-brain axis, including probiotics, prebiotics, postbiotics, fecal microbiota transplantation, and vagus nerve stimulation, represent promising approaches for symptom management. Further research is required to clarify their efficacy and establish personalized interventions. Improved understanding of gut-brain interactions in Long COVID may support the discovery of new biomarkers and targeted therapies for post-infectious disorders.
Downloads
References
1. Chen K, Wang Z, Li J, Xu Y, Gu S, Li H, Li J, Zhang Y, Mao N. Chronic inflammation in Long COVID relationship to autoimmune diseases. Autoimmun Rev. 2025;24(10):103882.
2. Smail SW, Albarzinji N, Salih RH, Taha KO, Hirmiz SM, Ismael HM, Noori MF, Azeez SS, Janson C. Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19. Front Cell Infect Microbiol. 2025;15:1537456
3. Talkington GMG, Kolluru P, Gressett TE, Sanders RD. Neurological sequelae of long COVID: A comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics. Front Neurol. 2025;146(12):122-140.
4. Chey WD, Almario CV, Choi SY, Moszkowski R, Barba E. Gut-brain interactions in long COVID: A comprehensive analysis of microbiota changes and functional GI disorders. Neurogastroenterol Motil. 2025;37(2):e70020.
5. Warunek A, Gronowicz G, Wanat J, Nowak P. Irritable bowel syndrome: An underestimated consequence of post-acute COVID-19. J Educ Health Sci. 2025;15(3):212230.
6. Lin T, Zhang Y, Wang J, Xu H. Gut microbiota dysregulation and neuroinflammation in post-COVID-19 cognitive dysfunction: Emerging evidence. Front Cell Infect Microbiol. 2025;154(2):289-305.
7. Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99(4):1877-2013.
8. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416-427.
9. Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival. Med Sci Monit. 2021;27:e930886.
10. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-146.
11. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-615.
12. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA, Hill C, et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Gut. 2019;68(11):1889-1898.
13. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332-1345.
14. Wegh CAM, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and their potential applications in early life nutrition and beyond. Benef Microbes. 2019;10(5):555-566.
15. de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M. Fecal microbiota transplantation in metabolic and gastrointestinal disorders. Gastroenterology. 2017;152(7):1777-1787.
16. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92.
17. Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. Bioelectronic Med. 2016;3:1-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
